CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...

Editas Medicine ( (EDIT) ) has provided an announcement. Editas Medicine announced new in vivo preclinical proof of concept data and outlined its strategic priorities and key milestones for 2025, ...

Jennifer Doudna, a UC Berkeley biochemist who shared the 2020 Nobel Prize in Chemistry for the invention of CRISPR-Cas9 ...

CRISPR-Cas9 pioneer presented with National Medal of Technology and Innovation in White House awards ceremony.

Gene editing involves precise changes in DNA sequences using enzymes, revolutionizing medical, agricultural, and research ...

Achieved in vivo preclinical proof of concept of editing hematopoietic stem cells in non-human primates as a key step toward developing a novel ...

Zhang, an MIT professor and a pioneer in gene-editing ... year. CRISPR-Cas9 technology – which allows scientists to precisely cut and modify DNA at specific locations within a genome – was ...

Researchers at the Broad Institute of MIT and Harvard have developed a gene-editing treatment for prion disease that extends ...

A live webcast of the presentation will be available on the“Investors” section of the Editas medicine website at . An archived replay will be available on the website for approximately 30 days ...

Biochemist Jennifer Doudna, a faculty scientist at the Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), founder of the ...

Genetic changes are a significant cause of infertility, impacting over 15% of the global population. TLE6, a major protein ...